Curtis Cluff is a hi-tech/biotech executive and business advisor, with extensive c-level industry experience. He has created and/or launched several highly successful professional brands including, SPF Rx, Lumixyl and SilkPeel Dermalinfusion, and Obagi-CRx. He also has start-up to IPO experience and an extensive record in building and managing accounting/finance, operations, sales, and marketing organizations for companies from private equity ventures to Fortune-500 corporations. Most recently, he has successfully launched new product brands in the following channels;
* Medical/Dermatology * Spa & High-End Resort * Amazon US & Amazon Global * Online eCommerce & Direct Response Markets * International Distribution in > 50 countries * Pro-Shop and Golf Industry Distribution
In doing so Curtis has garnered a very visible and respected reputation in the technology, skincare and medical device industries. Curtis served as the CEO of Envy Medical, Inc. in June 2009 to March 2016. During that time he led the company's successes in raising new capital and driving dramatic domestic and international sales growth by establishing new distribution channels/geographies, developing/launching Envy's first professional medical products while expanding SilkPeel indications. By the end of his tenure, Envy has become a medical channel leader with an active sales presence in over 45 countries worldwide.
Prior to joining Envy, Curtis was the President/COO for Colorescience Inc. (acquired by SkinMedica), establishing their medical channel strategy, professionalizing the sales force, and building an international presence. He also served in a number of executive roles for Obagi Medical Product, Inc.'s, where he was a primary architect in building the company into the #1 professional skin care brand in the United States, completing a successful IPO 2006.